IRIS
MONNO, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.795
EU - Europa 2.228
AS - Asia 854
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 13.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.784
CN - Cina 677
DE - Germania 503
SE - Svezia 490
IT - Italia 353
UA - Ucraina 329
FI - Finlandia 199
GB - Regno Unito 163
VN - Vietnam 65
BE - Belgio 46
RU - Federazione Russa 41
SG - Singapore 41
IE - Irlanda 39
FR - Francia 28
IN - India 28
HR - Croazia 11
IR - Iran 11
GR - Grecia 8
CA - Canada 7
ID - Indonesia 7
PK - Pakistan 7
CH - Svizzera 4
GE - Georgia 4
TR - Turchia 4
AT - Austria 3
CZ - Repubblica Ceca 3
EU - Europa 3
KE - Kenya 3
MX - Messico 3
NL - Olanda 3
PH - Filippine 3
ZA - Sudafrica 3
CL - Cile 2
HK - Hong Kong 2
HU - Ungheria 2
KZ - Kazakistan 2
PL - Polonia 2
AR - Argentina 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
TH - Thailandia 1
Totale 13.890
Salva come PNG Salva come JPEG
Città #
Fairfield 1.835
Woodbridge 1.199
Ashburn 849
Chandler 813
Houston 779
Jacksonville 769
Seattle 718
Wilmington 619
Cambridge 597
Ann Arbor 458
Nyköping 368
Roxbury 226
Lawrence 225
Nanjing 204
Princeton 141
Beijing 138
New York 135
Des Moines 122
Boardman 95
San Diego 75
Bari 71
Dong Ket 65
Inglewood 65
Shenyang 65
Nanchang 50
Hebei 49
Dublin 39
Tianjin 33
Brooklyn 32
Jiaxing 32
London 30
Singapore 27
Brussels 25
Helsinki 24
Los Angeles 24
Milan 23
Taranto 19
Rome 18
Changsha 17
Norwalk 16
Falls Church 15
Pune 15
Paris 14
Guangzhou 10
Washington 10
Zagreb 10
Dearborn 9
Redwood City 9
Bergamo 8
Florence 7
Shanghai 7
Vignola 7
Hounslow 6
Kilburn 6
Auburn Hills 5
Indiana 5
Jinan 5
Kunming 5
Magelang 5
New Bedfont 5
Taizhou 5
Ardabil 4
Bisceglie 4
Bologna 4
Edinburgh 4
Foggia 4
Lahore 4
Mola Di Bari 4
Ningbo 4
Perugia 4
Triggiano 4
Uster 4
Augusta 3
Boydton 3
Delhi 3
Detroit 3
Grinzane Cavour 3
Leawood 3
Munich 3
Ravenna 3
Renton 3
Rosà 3
San Francisco 3
San Jose 3
Tappahannock 3
Toronto 3
Weimar 3
Wuhan 3
Zhengzhou 3
Arnaia 2
Athens 2
Bedford 2
Brescia 2
Brindisi 2
Brno 2
Budapest 2
Carosino 2
Casamassima 2
Cassano d'Adda 2
Catania 2
Totale 11.374
Salva come PNG Salva come JPEG
Nome #
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 235
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 139
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 127
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 122
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 117
Co-receptor switch during HAART is independent of virological success 115
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 115
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 114
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 113
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 110
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 110
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 110
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 108
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 105
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 105
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 104
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 104
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 103
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 102
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 101
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 101
The elderly and direct antiviral agents: Constraint or challenge? 99
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 99
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 99
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 99
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 97
Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders. 97
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient 96
An outbreak of HIV-1 BC recombinants in Southern Italy 96
Access to health services for undocumented immigrants in Apulia. 96
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 96
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 95
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 94
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 94
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence 93
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 93
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 92
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 92
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 92
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 91
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 91
Prevalence and Clinical Characteristics of Mycobacterial Diseases in the Barletta-Andria-Trani Province, Italy (2005-2013) 90
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 89
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 88
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 86
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 86
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 85
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 85
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 85
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 85
Access to Health Services for Undocumented Immigrants in Apulia 84
Effects of HIV superinfection on HBV replication in a chronic HbsAg carrier with liver disease 84
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate 84
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. 84
Amoebic hepatic abscesses in an HIV-positive patient 83
Tuberculosis and diabetes: Current state and future perspectives 82
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 82
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 81
Are the proposed env mutations actually associated with resistance to maraviroc? 80
null 79
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 79
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 79
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 79
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 79
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis 78
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 78
null 78
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy. 77
Prevalence of mutations and determinants of genotypic resistance to Etravirine (tmc125) in a large Italian resistance database (ARCA) 77
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 77
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 77
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression 77
Rapid spread of HTLV-III infection among drug-addicts in Italy 76
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 76
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy. 75
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 75
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 75
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 74
Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men. 74
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 74
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy. 74
Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatments. 73
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 73
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 73
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 73
null 72
Liver abscess due to Fusobacterium necrophorum in an immunocompetent patient. A case report and review of the literature 72
null 71
Community-acquired pneumonia 71
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 71
Chronic cryptococcal meningitis in an intravenous drug addict without evidence of infection by HIV-1,2 in southern Italy 70
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 70
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 70
X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process. 69
null 69
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 69
Efficacy of protease inhibitor-based antiretroviral therapy in severe HIV-associated thrombocytopenia unresponsive to AZT 68
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 67
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period: A weighted analysis 67
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 67
Totale 8.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.767
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.765 0 271 122 419 535 272 401 424 557 291 341 132
2020/20212.645 210 248 205 229 392 105 272 181 218 308 114 163
2021/20221.406 74 166 16 91 60 116 70 113 97 94 198 311
2022/20232.285 410 181 116 204 280 314 25 244 403 19 47 42
2023/2024840 69 166 45 49 71 212 29 23 21 24 30 101
2024/202568 41 27 0 0 0 0 0 0 0 0 0 0
Totale 14.450